Cellectar Biosciences, Inc (CLRB) Stock Price

1.22 +0.00 (+0.00%)
Open: 1.205 Vol: 0 Day's range: 1.20 - 1.26 Oct 26, 15:59 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
CLRB Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.23▼ 1.24▼ 1.24▼ 1.22▼ 1.36▼
MA10 1.23▼ 1.24▼ 1.22▼ 1.21▲ 1.82▼
MA20 1.23▼ 1.22▼ 1.23▼ 1.42▼ 2.22▼
MA50 1.24▼ 1.21▲ 1.21▲ 2.00▼ 2.73▼
MA100 1.22▲ 1.27▼ 1.35▼ 2.28▼ 5.25▼
MA200 1.28▼ 1.50▼ 1.78▼ 2.68▼ 37.86▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.001▼ 0.000▲ 0.003▲ 0.016▲ -0.090▼
RSI 46.257▼ 47.291▼ 48.157▼ 28.979▼ 28.396▼
STOCH 47.727     72.421     84.248▲ 19.414▼ 3.851▼
WILL %R -66.667     -47.059     -47.059     -80.000▼ -93.671▼
CCI -106.562▼ -2.867     15.028     -42.602     -118.658▼
Latest Filters Detected On CLRB
▲ MACD $CLRB MACD(12,26,9) Crossed Above Signal Line Set Alert
MA $CLRB Price Crossed Above MA(7) Set Alert
CDL $CLRB Hammer Candlestick Pattern Detected Set Alert
CDL $CLRB Harami Candlestick Pattern Detected Set Alert
Cellectar Biosciences, Inc News
Cellectar (CLRB) phase 2b data shows durable responses in Waldenström macroglobulinemia
Tuesday, May 05, 2026 07:50 AM
Cellectar Biosciences, Inc. (NASDAQ:CLRB) reported updated Phase 2b data from its CLOVER WaM study, showing durable responses for iopofosine I 131 in relapsed or refractory Waldenström ...
Cellectar Biosciences Inc (CLRB) Q3 2025 Earnings Call Highlights: Strategic Advances and ...
Thursday, November 13, 2025 01:00 PM
Cellectar Biosciences Inc (NASDAQ:CLRB) has made significant advancements in its global regulatory strategy for iapofecine I-131, receiving confirmation of eligibility to file for conditional ...
Cellectar Biosciences (CLRB) Enters into Common Stock Agreements to Raise $2.5 Million Priced at Market Under Nasdaq Rules
Thursday, June 05, 2025 02:00 AM
Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced the entry ...
CLRB historical stock data
date open high low close volume
26/10/26 1.205 1.26 1.20 1.22 178,640
23/10/26 1.19 1.22 1.14 1.22 58,227
22/10/26 1.28 1.28 1.17 1.17 68,656
21/10/26 1.25 1.33 1.23 1.28 134,955
20/10/26 1.13 1.24 1.12 1.23 109,491
19/10/26 1.18 1.20 1.12 1.12 195,300
16/10/26 1.19 1.28 1.12 1.14 341,330
15/10/26 1.21 1.27 1.15 1.19 382,262
14/10/26 1.44 1.465 1.15 1.18 395,536
13/10/26 1.55 1.60 1.36 1.39 539,388
Quote Details
52wk Low:1.12
52wk High:4.70
Vol:0
Avg Vol(3m):1.7M
1Y Chng:-65.73%
1M Chng:-47.41%
Add to Watch List
More Information
Index US Composite
Market Cap. 11.06M